Free Submission Public Relations &
Deutsch English

Catalent Pharma Solutions, Inc. - SWOT, Strategy and Corporate Finance Report

Catalent Pharma Solutions, Inc. - SWOT, Strategy and Corporate Finance Report - new company profile report published

Print article Print article
2013-01-21 09:17:02 - Catalent Pharma Solutions, Inc. - SWOT, Strategy and Corporate Finance Report - a new company profile report on

Catalent Pharma Solutions, Inc. - SWOT, Strategy and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company´s structure, operation, SWOT analysis, product and service offerings, detailed financials, and corporate actions, providing a 360˚ view of the company.


- Detailed information on Catalent Pharma Solutions, Inc. required for business and competitor intelligence needs
- A study of the major internal and external factors affecting Catalent Pharma Solutions, Inc. in the form of a SWOT analysis
- An in-depth view of the business model of Catalent Pharma Solutions, Inc. including a breakdown and examination of key business segments
- Five-year financial information and charts, including balance sheet, income statement, cash flows, market capitalization and multiples, and key ratios



for Catalent Pharma Solutions, Inc.
- Intelligence on Catalent Pharma Solutions, Inc.nv´s mergers and acquisitions (M&A), strategic partnerships and alliances, capital raising, private equity transactions, and financial and legal advisors
- News about Catalent Pharma Solutions, Inc., such as business expansion, restructuring, and contract wins
- Large number of easy-to-grasp charts and graphs that present important data and key trends


Catalent Pharma Solutions (Catalent), owned by The Blackstone Group, is one of the leading providers of advanced dose form and packaging technologies, and development, manufacturing, packaging and printing services for pharmaceutical, biotechnology and consumer healthcare companies in about 100 countries. The company operates in North America, Europe, South America and Asia-Pacific regions. It is headquartered in Somerset, New Jersey and employed about 8,200 people as of June 30, 2011. The company recorded revenues of $1,640.3 million during the financial year (FY) ended June 2011, an increase of 0.9% over FY2010. The operating profit of the company was $177.4 million during FY2011, as compared with an operating loss of $90.5 million in FY2010. The net loss was $50.1 million in FY2011, as compared to a net loss of $287 million in FY2010.
Reasons to Purchase:

- Gain understanding of Catalent Pharma Solutions, Inc. and the factors that influence its strategies
- Track strategic initiatives of the company and latest corporate news and actions
- Assess Catalent Pharma Solutions, Inc. as a prospective partner, vendor or supplier
- Support sales activities by understanding your customers´ businesses better
- Stay up to date on Catalent Pharma Solutions, Inc.´s business structure, strategy and prospects

Click for report details: ..

Browse all Healthcare and Medical Company Profile Reports ..

Browse all Healthcare and Medical Company Profile Reports ..

Browse all Latest Company Profile Reports ..

About Us is a leading online business information aggregator with over 300,000 market reports and company profiles available to our clients. Our extensive range of reports are sourced from the leading publishers of business information and provide clients with the widest range of information available. In terms of company profiles,’s online database allows clients access to market and corporate information to over 100,000 different companies. We provide clients with a fully indexed database of information where clients can find specific market reports on their niche industry sectors of interest.

Mike King
Phone: London: +44 (0) 203 086 8600

Disclaimer: If you have any questions regarding information in these press releases please contact the company added in the press release. Please do not contact pr-inside. We will not be able to assist you. PR-inside disclaims contents contained in this release.
Latest News
Read the Latest News


Terms & Conditions | Privacy | About us | Contact